The Gary Null Show - 07.14.22

Quercetin phytosome reduced allergy symptoms in clinical trial University of Shizuoka (Japan), July 11 2022.  A randomized trial described in the European Review for Medical and Pharmacological Sciences revealed a decrease in seasonal allergy symptoms among men and women who were given quercetin, a flavonoid that occurs in fruits, tea, onions and herbs.  The trial included 60 participants who reported experiencing eye and nasal symptoms related to pollen or house dust exposure. Half of the participants received 200 milligrams quercetin phytosome (a food-grade bioavailable formulation of quercetin) and the remainder received a placebo daily for 4 weeks. Blood samples were analyzed for various factors and quality of life questionnaires that evaluated eye and nasal symptoms were administered before the treatment period and at 2 and 4 weeks.  At the end of the study, eye itching, sneezing, nasal discharge and sleep disorder scores, were significantly improved among participants who received quercetin in comparison with participants who received a placebo. Severity of sneezing, nasal discharge and disturbance of daily living were lower at the end of various time points among supplemented participants compared to the placebo group.    Kiwi fruit powder shows gut health benefits Medicus Research (New Zealand), July 10, 2022 Kiwifruit containing Zyactinase called Kivia may enhance bowel movement frequency and improve other symptoms of occasional constipation, say new data from a randomized clinical trial. A daily 5.5 gram dose of Kivia powder was associated with a reduction in abdominal pain and flatulence in subjects with occasional constipation, according to findings published in the Nutrition Journal . While the exact mechanism of action is still to be elucidated, researchers led by Dr Jay Udani at Medicus Research note that kiwifruit extract is rich in enzymes able to aid in digestion, as well as potential prebiotics which may enhance the growth of beneficial bacteria in the gut. “Improvements were noted in the number of bowel movements, with increased bowel movements in the group using the studied extract,” they wrote. “There were also improvements observed in bowel health and stool formation. “This suggests that Kivia powder improved bowel habits in this group of subjects.” Results showed that the Kivia group experienced significant increases in spontaneous bowel movements at every week, compared to data from the start of the study. Significant differences were also observed between the kiwifruit extract group and placebo at weeks 3 and 4.     Lifestyle may be more important than age in determining dementia risk: Study Baycrest Centre for Geriatric Care, July 13, 2022 Individuals with no dementia risk factors, such as smoking, diabetes or hearing loss, have similar brain health as people who are 10 to 20 years younger than them, according to a new Baycrest study. The study found that a single dementia risk factor could reduce cognition by the equivalent of up to three years of aging. "Our results suggest lifestyle factors may be more important than age in determining someone's level of cognitive functioning. This is great news, since there's a lot you can do to modify these factors, such as managing diabetes, addressing hearing loss, and getting the support you need to quit smoking," says Dr. Annalise LaPlume, Postdoctoral Fellow at Baycrest's Rotman Research Institute (RRI) and the study's lead author. The study is one of the first to look at lifestyle risk factors for dementia across the entire lifespan. The study, published in the journal Alzheimer's & Dementia: Diagnosis, Assessment, and Disease Monitoring, a journal of the Alzheimer's Association, included data from 22,117 people aged 18 to 89. The researchers looked at participants' performance on memory and attention tests, and how this was impacted by eight modifiable risk factors for dementia: low education (less than a high school diploma), hearing loss